Cytologic rapid on-site evaluation of transthoracic computed tomography–guided lung needle biopsies: who should perform ROSE? A cross-institutional analysis of procedural and diagnostic outcomes

Touch imprint (TI) cytology of needle core biopsies (NCB) in pathology laboratories: A practice survey of participants in the College of American Pathologists (CAP) Non Gynecologic Cytopathology (NGC) Education Program

“…Each case was reported separately by a cytopathologist and a surgical pathologist, respectively. This was different from the way specimens were handled at DHMC, where the entire case was accessioned as a cytology specimen and signed out by the cytopathologist . The practice at DHMC is consistent with the practices by most laboratories noted in our survey.…”

“…In the study by Gupta and Wang, TI slides were signed out by cytopathologists while core biopsies were independently signed out by surgical pathologists. Marotti et al compared processes between 2 hospitals: Dartmouth‐Hitchcock Medical Center (DHMC) (where rapid on‐site assessment [ROSE] is performed by cytopathologists) and the Beth Israel Deaconess Medical Center (BIDMC) (where ROSE is rendered by either cytotechnologists or cytopathology fellows) . The practice in BIDMC as noted by Marotti et al was to accession TI slides or FNA material as a cytology case and accession the formalin‐fixed paraffin embedded NCB as a separate surgical pathology case.…”

“…Most often (87.4%; 334/382), a single final report was rendered which included the immediate assessment result of the TI, the TI findings and the NCB diagnosis (Table ). Less often (13.4%; 51/382) 2 separate reports were rendered‐ one for the TI adequacy/TI findings, and one for the NCB as noted in the model from BIDMC in the study by Marotti et al Most of the time (91.8%; 45/49) in those instances, the findings on the two reports were cross‐referenced. Ancillary tests were performed most commonly on formalin‐fixed tissue from the NCB (96.2%; 329/342), or from needle rinses or additional FNA passes performed for cell blocks (62.3%; 213/342) (Table ).…”

“…This may be due to the reimbursement system, where adequacy assessment is reimbursed only when it is performed by a pathologist. Marotti et al compared processes between DHMC and BIDMC and showed that diagnostic outcomes for transthoracic CT‐guided lung biopsies were similar for adequacy assessments from cytopathologists, cytotechnologists, and cytopathology fellows. This process may change in time.…”

Cytotechnologist Performance for Screening Hürthle Cell Atypia in Indeterminate Thyroid Fine-Needle Aspirates

“…With the ever-declining frequency of Pap tests in current cervical cancer screening algorithms, nongynecological cytology roles for CTs need to be formalized and possibly expanded so that their true worth in the system of delivering health care can be better known. For example, their role in the performance of on-site evaluation of adequacy (OSEA, also known as rapid on-site evaluation, ROSE) is well established, with a growing basis of evidence [1,2,3,4,5]. Other roles include cytological-molecular correlation [6] and the screening of nongynecological specimens [7].…”